Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15920553rdf:typepubmed:Citationlld:pubmed
pubmed-article:15920553lifeskim:mentionsumls-concept:C0033325lld:lifeskim
pubmed-article:15920553lifeskim:mentionsumls-concept:C0079744lld:lifeskim
pubmed-article:15920553lifeskim:mentionsumls-concept:C0079611lld:lifeskim
pubmed-article:15920553lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:15920553pubmed:issue8lld:pubmed
pubmed-article:15920553pubmed:dateCreated2005-7-21lld:pubmed
pubmed-article:15920553pubmed:abstractTextDiffuse large B-cell lymphoma (DLBCL) has been shown to be comprised of at least two prognostic entities, depending on its resemblance to normal germinal center or activated B cells, using global gene expression profiling. Also, the expression patterns of bcl-6, CD10 and IRF-4 (also known as MUM1) have been suggested as alternative means of identifying the germinal- and nongerminal center (activated B-cell like) groups. In the present study, we evaluated by immunohistochemistry the expression patterns of CD10, bcl-6, IRF-4 and bcl-2 in a large material of 161 DLBCL patients. Using two different approaches, patients with germinal center phenotype displayed a significantly better survival than the nongerminal center group. Positive staining for bcl-6 or CD10 predicted for superior survival, while expression of IRF-4 alone showed no association with prognosis. Furthermore, expression of bcl-2 was associated with worse event-free survival and overall survival. In a multivariate analysis, a high international prognostic index score (3-5), non-GC phenotype and bcl-2 were independent adverse prognostic factors. Here we confirm the prognostic importance of determining the germinal- or nongerminal center phenotype in patients with DLBCL.lld:pubmed
pubmed-article:15920553pubmed:languageenglld:pubmed
pubmed-article:15920553pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920553pubmed:citationSubsetIMlld:pubmed
pubmed-article:15920553pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920553pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920553pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920553pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920553pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920553pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920553pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920553pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920553pubmed:statusMEDLINElld:pubmed
pubmed-article:15920553pubmed:monthAuglld:pubmed
pubmed-article:15920553pubmed:issn0893-3952lld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:DictorMichael...lld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:BookMajlisMlld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:ThunbergUlfUlld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:EnbladGunilla...lld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:SundströmChri...lld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:RoosGöranGlld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:RosenquistRic...lld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:HagbergHansHlld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:BacklinCarinClld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:AminiRose-Mar...lld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:ErlansonMarti...lld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:BerglundMatti...lld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:Cavallin-Ståh...lld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:LinderothJoha...lld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:JerkemanMatsMlld:pubmed
pubmed-article:15920553pubmed:authorpubmed-author:Rehn-Eriksson...lld:pubmed
pubmed-article:15920553pubmed:issnTypePrintlld:pubmed
pubmed-article:15920553pubmed:volume18lld:pubmed
pubmed-article:15920553pubmed:ownerNLMlld:pubmed
pubmed-article:15920553pubmed:authorsCompleteYlld:pubmed
pubmed-article:15920553pubmed:pagination1113-20lld:pubmed
pubmed-article:15920553pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:meshHeadingpubmed-meshheading:15920553...lld:pubmed
pubmed-article:15920553pubmed:year2005lld:pubmed
pubmed-article:15920553pubmed:articleTitleEvaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.lld:pubmed
pubmed-article:15920553pubmed:affiliationDepartment of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden. Mattias.Berlund@genpat.uu.selld:pubmed
pubmed-article:15920553pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15920553pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920553lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920553lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920553lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920553lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920553lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920553lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920553lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920553lld:pubmed